IRIS
SAMMARTINO, JOSE' CAMILLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.003
AS - Asia 1.553
EU - Europa 1.009
SA - Sud America 211
AF - Africa 78
OC - Oceania 1
Totale 4.855
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.926
CN - Cina 433
SG - Singapore 412
VN - Vietnam 235
HK - Hong Kong 229
RU - Federazione Russa 198
BR - Brasile 157
DE - Germania 154
IE - Irlanda 150
IT - Italia 139
FI - Finlandia 94
FR - Francia 83
GB - Regno Unito 59
IN - India 53
ZA - Sudafrica 48
CA - Canada 46
BD - Bangladesh 37
JP - Giappone 35
ES - Italia 26
MX - Messico 22
TR - Turchia 21
SE - Svezia 20
PL - Polonia 19
PK - Pakistan 15
IQ - Iraq 14
NL - Olanda 14
AT - Austria 13
PH - Filippine 13
VE - Venezuela 11
ID - Indonesia 10
AR - Argentina 9
EC - Ecuador 9
SA - Arabia Saudita 7
CL - Cile 6
CO - Colombia 6
CZ - Repubblica Ceca 6
MY - Malesia 6
TN - Tunisia 6
UZ - Uzbekistan 6
CH - Svizzera 5
LT - Lituania 5
PE - Perù 5
UA - Ucraina 5
BE - Belgio 4
EG - Egitto 4
JM - Giamaica 4
KE - Kenya 4
MA - Marocco 4
BO - Bolivia 3
DZ - Algeria 3
KG - Kirghizistan 3
KZ - Kazakistan 3
PT - Portogallo 3
PY - Paraguay 3
RO - Romania 3
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
JO - Giordania 2
KR - Corea 2
LB - Libano 2
OM - Oman 2
TH - Thailandia 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CR - Costa Rica 1
CV - Capo Verde 1
DM - Dominica 1
ET - Etiopia 1
GA - Gabon 1
GR - Grecia 1
IR - Iran 1
KW - Kuwait 1
MN - Mongolia 1
MU - Mauritius 1
MZ - Mozambico 1
NA - Namibia 1
NI - Nicaragua 1
NO - Norvegia 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
TG - Togo 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
Totale 4.855
Salva come PNG Salva come JPEG
Città #
San Jose 332
Singapore 226
Hong Kong 225
Ashburn 209
Dallas 190
Dublin 142
Beijing 132
Chandler 121
New York 101
Ho Chi Minh City 87
Munich 84
Boardman 72
Los Angeles 66
Helsinki 65
Lauterbourg 54
Shanghai 51
Hanoi 50
Council Bluffs 45
Johannesburg 39
Moscow 32
Santa Clara 30
Redondo Beach 29
Turku 29
The Dalles 27
Pavia 25
Milan 24
Tokyo 24
Orem 23
Princeton 20
Lawrence 19
Buffalo 18
Medford 18
Toronto 17
Warsaw 17
Denver 16
Frankfurt am Main 16
Montreal 15
Seattle 15
Stockholm 15
Chicago 14
São Paulo 14
Chennai 13
Wilmington 13
Columbus 12
Biên Hòa 11
Brooklyn 11
Da Nang 11
Poplar 11
Rome 11
Amsterdam 10
Boston 10
Mexico City 10
Nuremberg 10
Charlotte 9
Düsseldorf 9
Haiphong 9
London 9
Washington 9
Ann Arbor 8
Houston 8
Lecce 8
Atlanta 7
Baghdad 7
Changsha 7
Hangzhou 7
Hải Dương 7
Mumbai 7
Nanjing 7
Phoenix 7
Shenyang 7
Ankara 6
Falkenstein 6
Jakarta 6
Lahore 6
Manchester 6
Tashkent 6
Utrera 6
Belo Horizonte 5
Brasília 5
Dhaka 5
Istanbul 5
New Delhi 5
San Francisco 5
Cairo 4
Dearborn 4
Florence 4
Honolulu 4
Jeddah 4
Karachi 4
Medellín 4
Nanchang 4
Olomouc 4
Piscataway 4
Asunción 3
Bishkek 3
Bologna 3
Boves 3
Brussels 3
Bến Tre 3
Cao Lanh 3
Totale 3.146
Salva come PNG Salva come JPEG
Nome #
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 157
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 130
19n01, a Broadly Neutralizing Antibody Against Omicron BA.1, BA.2, BA.4/5, and Other SARS-CoV-2 Variants of Concern 124
An Overview on the Potential Antimycobacterial Agents Targeting Serine/Threonine Protein Kinases from Mycobacterium tuberculosis 120
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 118
Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice 114
SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers 113
New insights into the mechanism of action of the thienopyrimidine antitubercular prodrug TP053 111
Rv0579 Is Involved in the Resistance to the TP053 Antitubercular Prodrug 110
Design and Synthesis of Pyrano[3,2-b]indolones Showing Antimycobacterial Activity 110
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 109
Characterization of immune response against monkeypox virus in cohorts of infected patients, historic and newly vaccinated subjects 106
First triclosan-based macrocyclic inhibitors of InhA enzyme 103
Differential Kinetics of Effector and Memory Responses Induced by Three Doses of SARS-CoV-2 mRNA Vaccine in a Cohort of Healthcare Workers 101
Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents 101
Targeting iron uptake pathway for the development of novel antitubercular drugs. 100
Functional investigation of the antitubercular drug target Decaprenylphosphoryl-β-D-ribofuranose-2-epimerase DprE1/DprE2 complex 99
Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study 98
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study 93
Macrophages and monocytes: “trojan horses” in covid-19 91
Humoral and cellular response before and after the fourth BNT162b2 vaccine dose in patients with solid tumors on active treatment 90
Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ∼40% of patients 90
Immunity to SARS-CoV-2 up to 15 months after infection 89
Multitargeting Compounds: A Promising Strategy to Overcome Multi-Drug Resistant Tuberculosis 89
Effect of a Third Dose of SARS-CoV-2 mRNA BNT162b2 Vaccine on Humoral and Cellular Responses and Serum Anti-HLA Antibodies in Kidney Transplant Recipients 87
Variant of Concern-Matched COVID-19 Convalescent Plasma Usage in Seronegative Hospitalized Patients 86
Effect of different surface treatments on titanium dental implant micro-morphology 86
Immunosuppressive treatments selectively affect the humoral and cellular response to SARS-CoV-2 in vaccinated patients with vasculitis 82
Dynamics of viral DNA shedding and culture viral DNA positivity in different clinical samples collected during the 2022 mpox outbreak in Lombardy, Italy 81
Clinical Influence of Micromorphological Structure of Dental Implant Bone Drills 81
Comparative analysis of the chemical composition and microstructure conformation between different dental implant Bone Drills 78
Adapting Neutralizing Antibodies to Viral Variants by Structure-Guided Affinity Maturation Using Phage Display Technology 78
Effect of Low Copper Doping on the Optical, Cytocompatible, Antibacterial, and SARS-CoV-2 Trapping Properties of Calcium Phosphate Glasses 74
In vitro Study of Bedaquiline Resistance in Mycobacterium tuberculosis Multi-Drug Resistant Clinical Isolates. 74
The 2023 dengue outbreak in Lombardy, Italy: A one-health perspective 73
Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients. 73
Shedding X-ray light on the role of magnesium in the activity of M. tuberculosis salicylate synthase (MbtI) for drug design 73
Effect of different titanium dental implant surfaces on human adipose mesenchymal stem cell behavior. An in vitro comparative study 72
The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme 72
Annotation process, guidelines and text corpus of small non-coding RNA molecules: The MiNCor for microRNA annotations 71
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents 71
Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concern 69
Neutralizing antibody levels against SARS-CoV-2 variants of concern Delta and Omicron in vaccine breakthrough-infected blood donors 68
Evaluation of the Neutralizing Antibodies Response against 14 SARS-CoV-2 Variants in BNT162b2 Vaccinated Naïve and COVID-19 Positive Healthcare Workers from a Northern Italian Hospital 68
Robust and persistent b-and t-cell responses after covid-19 in immunocompetent and solid organ transplant recipient patients 68
Real-life lack of evidence of viable SARS-CoV-2 transmission via inanimate surfaces: The SURFACE study 67
High-throughput peptide array analysis and computational techniques for serological profiling of flavivirus infections: Implications for diagnostics and vaccine development 65
Local delivery of the hemostatic agent tranexamic acid in chronically anticoagulated patients 65
mRNA BNT162b Vaccine Elicited Higher Antibody and CD4+ T-Cell Responses than Patients with Mild COVID-19 64
Characterization of CCP: Can We Use Past Convalescent Plasma from COVID-19 Patients for Treatment of New Emerging Variants? 63
Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant 63
P146 New weapons are necessary to fight Mycobacterium abscessus 57
Immune response to bnt162b2 in solid organ transplant recipients: Negative impact of mycophenolate and high responsiveness of sars-cov-2 recovered subjects against delta variant 55
SARS-CoV-2 variants inactivation of plasma units using a riboflavin and ultraviolet light-based photochemical treatment 54
Platelet-rich plasma counteracts detrimental effect of high-glucose concentrations on mesenchymal stem cells from Bichat fat pad 53
White cell and platelet content affects the release of bioactive factors in different blood-derived scaffolds 51
Genotyping of Toxoplasma gondii strain directly from human CSF samples of congenital toxoplasmosis clinical case 48
Micro-scale surface patterning of titanium dental implants by anodization in the presence of modifying salts 44
Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant 36
Fitness cost of rifampin resistance in Neisseria meningitidis: In Vitro study of mechanisms associated with rpoB H553Y mutation 36
Selection of Functional Glycoforms in Anti-SARS-CoV-2 Human IgG1 Monoclonal Antibodies by FcγRIIIa Affinity Chromatography and Mass Spectrometry 12
Totale 4.984
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.271
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.271
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/2022100 0 1 0 9 1 1 3 6 6 12 11 50
2022/2023448 32 40 3 29 27 24 0 16 240 13 21 3
2023/2024477 44 90 32 23 38 126 35 24 2 16 12 35
2024/20251.126 28 68 15 22 24 76 73 51 278 74 164 253
2025/20262.713 195 161 285 334 308 108 589 154 241 160 112 66
Totale 4.984